INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
Public company

DWTXDogwood Therapeutics, Inc.

CIK 0001818844

EDGAR filingsOpen in network
Disclosed transactions4
Buys / sells0 / 0
Max Insider Score9
Connections5with evidence

DWTX · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
DS
Duncan Gregory ScottDirector, CHIEF EXECUTIVE OFFICER
DWTXDogwood Therapeutics, Inc.
Grant or award
A—
460.0K sh
Dec 4, 2025Dec 5, 2025
traded Dec 4, 2025
+1dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 5, 2026
  • ← Insider ofevidence
    Duncan Gregory ScottDirector, CHIEF EXECUTIVE OFFICER · Dec 5, 2025
  • ← Insider ofevidence
    Gendreau Roger MichaelCHIEF MEDICAL OFFICER · Dec 5, 2025
  • ← Insider ofevidence
    Grosswald RalphSVP OF OPERATIONS · Dec 5, 2025
9
GM
Gendreau Roger MichaelCHIEF MEDICAL OFFICER
DWTXDogwood Therapeutics, Inc.
Grant or award
A
—
150.0K sh
Dec 4, 2025
Dec 5, 2025
traded Dec 4, 2025
+1d
SEC FORM 4

Evidence

9
GR
Grosswald RalphSVP OF OPERATIONS
DWTXDogwood Therapeutics, Inc.
Grant or award
A—
150.0K sh
Dec 4, 2025Dec 5, 2025
traded Dec 4, 2025
+1dSEC FORM 4

Evidence

9
WA
Walsh AngelaChief Financial Officer
DWTXDogwood Therapeutics, Inc.
Grant or award
A—
150.0K sh
Dec 4, 2025Dec 5, 2025
traded Dec 4, 2025
+1dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Walsh AngelaChief Financial Officer · Dec 5, 2025